Neuromodulation Market Major Manufacturers, Trends, Demand, Analysis and Forecasts To 2027


Posted March 2, 2023 by Ajaymhatale

According to the latest study on “Neuromodulation Market Forecast to 2027 –COVID-19 Impact and Global Analysis – by Technology, Application, and End User

 
Neuromodulation Market report 2023 is a professional and in-depth survey on the current state of the Market. The report provides a basic overview of the Market including definitions, classifications, applications and Market chain structure. Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.

An exclusive Neuromodulation Market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa.

According to the latest study on “Neuromodulation Market Forecast to 2027 –COVID-19 Impact and Global Analysis – by Technology, Application, and End User,” the market was valued at US$ 7,613.45 million in 2019 and is projected to reach US$ 16,333.98 million by 2027; it is expected to grow at a CAGR of 10.3% during 2020–2027. The report highlights trends prevailing in the global neuromodulation market, and drivers and restraints pertaining to the market growth.

The growth of the neuromodulation market is driven by the factors such as increasing incidence of neurological disorders and growing developments in neuromodulation technology. Further, the rising demand of neurostimulation devices to treat chronic pain offer lucrative opportunities to the global neuromodulation market players. However, the high cost of neuromodulation devices hinders the market growth.

Request sample pages of this research study at –

https://www.theinsightpartners.com/sample/TIPHE100001415/

The prominent/emerging players in the Neuromodulation Market research include:

Abbott
Boston Scientific Corporation
Medtronic
NeuroPace, Inc.
NeuroSigma, Inc.
NEVRO CORP.
Synapse Biomedical Inc.
Soterix Medical Inc
Integer Holdings Corporation
On the basis of technology, the neuromodulation market is bifurcated into external (non-invasive) neuromodulation and internal neuromodulation. In 2019, the internal neuromodulation segment accounted for a larger share of the market. The growth of the market for this segment is attributed to the rising number of product launches and increasing innovations in neuromodulation devices.

About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Ajay
Country India
Categories Blogging
Last Updated March 2, 2023